Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PB-119 vs placebo in untreated type 2 diabetes mellitus
CTR20201492Phase 3Completed
- Sponsor
- PegBio
- Start
- Jul 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of visepegenatide in type 2 diabetes mellitus (T2DM), sponsored by PegBio. Started Jul 2020; status: completed.
02
Drugs
visepegenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20201492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201492.